According to Vertex Pharmaceuticals, approximately 300 additional people with CF are now eligible to receive treatment.

Sophie Pierce is determined to make the most of her life - however long she may have.

LCI proves valuable in monitoring ETI therapy effectiveness for cystic fibrosis patients with minimal FEV1 changes, detecting ...

The Food and Drug Administration (FDA) has approved Alyftrek ™ (vanzacaftor/tezacaftor/deutivacaftor) for the treatment of cystic fibrosis (CF) in patients aged 6 years and older who have at least one ...

THE first person in the UK to have all of her major organs transplanted has died aged 46 – more than a decade after her ...

Allison was seven years old when she was told she was one of 10% of cystic fibrosis patients in the world with liver disease.

Throughout Gunnar Esiason's journey with cystic fibrosis, the sport of hockey has always been huge part of his family. See ...

The new combination, dubbed Alyftrek, is designed to improve on the Trikafta, a product that generated sales of $8.9 billion ...

As Vertex Pharmaceuticals reels from a painful trial readout for its pain candidate suzetrigine, the Boston biotech has ...

The US Food and Drug Administration has approved Alyftrek, a once-daily oral combination of vanzacaftor, tezacaftor, and ...